2 completed, 2 terminated, 1 unknown, 1 withdrawn. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 2, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Peripheral Arterial Occlusive Disease: new trials by email Literature Review of Peripheral Arterial Occlusive Disease trials Research Report on Peripheral Arterial Occlusive Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions Point of care screening for HPR, Ticagrelor 90mg - Peripheral Artery Disease, Clopidogrel, Poor Metabolism of | Phase 3 | Terminated | Marissa Jarosinski | 31 | 2019-08-09 | 2026-07-06 |
| Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication Sildenafil 100mg single oral dose, Placebo, Oral intake single dose - Peripheral Arterial Occlusive Disease | Phase 3 | Completed | University Hospital, Angers | 14 | 2016-11-07 | 2022-07-29 |
| EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study Spectranetics Turbo elite™ excimer laser catheter - Peripheral Arterial Occlusive Disease | Phase 2 / Phase 3 | Terminated | Flanders Medical Research Program | 14 | 2008-07-01 | 2015-03-09 |
| FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study 4.0-5.0mm AngioSculpt Scoring Balloon Catheter - Peripheral Arterial Occlusive Disease | Phase 2 / Phase 3 | Completed | Flanders Medical Research Program | 50 | 2008-03-01 | 2010-07-05 |
| Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia Autologous bone marrow cell concentrate transplantation, saline injection - Peripheral Vascular Disease, Diabetic Foot | Phase 2 / Phase 3 | Unknown | Franziskus-Krankenhaus | 90 | 2007-04-01 | 2011-04-06 |
| Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication Sildenafil 100 mg oral morning dose, Placebo oral morning dose - Peripheral Arterial Occlusive Disease | Phase 3 | Withdrawn | University Hospital, Angers | 2018-11-06 |
Peripheral Arterial Occlusive Disease 1 (6) · Peripheral Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Diabetic Foot (1) · Gangrene (1) · Ischemia (1) · Leg Ulcer (1) · Peripheral Arterial Disease (1)
Cardiovascular Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Endocrine System Diseases (1) · Foot Ulcer (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1)
Sildenafil Citrate (2) · Sodium Chloride (1) · Ticagrelor (1)
Flanders Medical Research Program (2) · University Hospital, Angers (2) · Franziskus-Krankenhaus (1) · Marissa Jarosinski (1)
Belgium (2) · Germany (2) · United States (1)
Patrick Peeters, MD (2) · Berthold Amann, MD (1) · Marc Bosiers, MD (1)